The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 13, 2021
Filed:
Oct. 04, 2019
Applicant:
Adt Pharmaceuticals, Llc, Orange Beach, AL (US);
Inventors:
Gary A. Piazza, Daphne, AL (US);
Xi Chen, Hoover, AL (US);
Adam B. Keeton, Gardendale, AL (US);
Michael R. Boyd, Orange Beach, AL (US);
Assignee:
ADT Pharmaceuticals, LLC, Orange Beach, AL (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 317/64 (2006.01); A61K 31/445 (2006.01); A61K 31/44 (2006.01); A61K 31/40 (2006.01); A61K 31/401 (2006.01); A61K 31/36 (2006.01); A61K 31/341 (2006.01); C07D 211/56 (2006.01); C07D 213/75 (2006.01); C07D 207/14 (2006.01); C07D 207/337 (2006.01); C07D 307/54 (2006.01); C07C 235/32 (2006.01); C07C 237/20 (2006.01); C07D 235/30 (2006.01); C07D 405/12 (2006.01); C07D 213/24 (2006.01); C07D 307/38 (2006.01); C07D 307/52 (2006.01); A61K 45/06 (2006.01); C07C 233/58 (2006.01);
U.S. Cl.
CPC ...
C07D 317/64 (2013.01); A61K 31/341 (2013.01); A61K 31/36 (2013.01); A61K 31/40 (2013.01); A61K 31/401 (2013.01); A61K 31/44 (2013.01); A61K 31/445 (2013.01); A61K 45/06 (2013.01); C07C 233/58 (2013.01); C07C 235/32 (2013.01); C07C 237/20 (2013.01); C07D 207/14 (2013.01); C07D 207/337 (2013.01); C07D 211/56 (2013.01); C07D 213/24 (2013.01); C07D 213/75 (2013.01); C07D 235/30 (2013.01); C07D 307/38 (2013.01); C07D 307/52 (2013.01); C07D 307/54 (2013.01); C07D 405/12 (2013.01); A61K 2300/00 (2013.01); C07C 2601/02 (2017.05); C07C 2602/08 (2017.05);
Abstract
Disclosed are compounds, for example, compounds of formula I, wherein R, R, R-R, n, X, Y, Y', and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a disease or condition, for example, cancer.